{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:53:24Z","timestamp":1787849604592,"version":"build-2784847793"},"reference-count":31,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,10,29]]},"DOI":"10.3233\/jad-190639","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T14:56:59Z","timestamp":1569337019000},"page":"191-197","source":"Crossref","is-referenced-by-count":45,"title":["Effect of Advanced Glycation End Products on the Progression of Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"72","author":[{"given":"Ping-Song","family":"Chou","sequence":"first","affiliation":[{"name":"Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of and Master\u2019s Program in Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ni","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of and Master\u2019s Program in Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Cheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Environmental and Occupational Medicine, and Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Environmental and Occupational Medicine, and Health Management Center, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ting","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Family Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Han","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of and Master\u2019s Program in Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Neuroscience Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Neurology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190639_ref1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.arcmed.2012.11.003","article-title":"Epidemiology of dementias and Alzheimer\u2019s disease","volume":"43","author":"Sosa-Ortiz","year":"2012","journal-title":"Arch Med Res"},{"key":"10.3233\/JAD-190639_ref2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","article-title":"An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer\u2019s disease","volume":"124","author":"Zhang","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl 2","key":"10.3233\/JAD-190639_ref3","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.3233\/JAD-2011-111127","article-title":"Alzheimer\u2019s disease and diabetes: An integrative view of the role of mitochondria, oxidative stress, and insulin","volume":"30","author":"Moreira","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190639_ref4","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/db13-1954","article-title":"Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease","volume":"63","author":"De Felice","year":"2014","journal-title":"Diabetes"},{"key":"10.3233\/JAD-190639_ref5","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction","volume":"379","author":"McCrimmon","year":"2012","journal-title":"Lancet"},{"key":"10.3233\/JAD-190639_ref6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1212\/WNL.0000000000001982","article-title":"Type 2 diabetes mellitus and biomarkers of neurodegeneration","volume":"85","author":"Moran","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-190639_ref7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcjd.2016.07.003","article-title":"Effects of diabetes mellitus on cognitive decline in patients with Alzheimer disease: A systematic review","volume":"41","author":"Li","year":"2017","journal-title":"Can J Diabetes"},{"key":"10.3233\/JAD-190639_ref8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.diabres.2004.09.004","article-title":"Advanced glycation endproducts\u2014 role in pathology of diabetic complications","volume":"67","author":"Ahmed","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.3233\/JAD-190639_ref9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2796.2002.00932.x","article-title":"Diabetes and advanced glycation endproducts","volume":"251","author":"Vlassara","year":"2002","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-190639_ref10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2478\/s11658-014-0205-5","article-title":"The role of advanced glycation end products in various types of neurodegenerative disease: A therapeutic approach","volume":"19","author":"Salahuddin","year":"2014","journal-title":"Cell Mol Biol Lett"},{"key":"10.3233\/JAD-190639_ref11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1210\/jc.2014-2754","article-title":"Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: The maastricht study","volume":"100","author":"Spauwen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JAD-190639_ref12","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1017\/S1041610217000886","article-title":"Association between advanced glycation end-products and functional performance in Alzheimer\u2019s disease and mixed dementia","volume":"29","author":"Drenth","year":"2017","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-190639_ref13","doi-asserted-by":"crossref","first-page":"636 e637","DOI":"10.1016\/j.jamda.2017.04.004","article-title":"Advanced glycation end-products are associated with the presence and severity of paratonia in early stage Alzheimer disease","volume":"18","author":"Drenth","year":"2017","journal-title":"J Am Med Dir Assoc"},{"key":"10.3233\/JAD-190639_ref14","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): Current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-190639_ref15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-190639_ref16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-190639_ref17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000066024","article-title":"Cutoff scores of the cognitive abilities screening instrument, Chinese version in screening of dementia","volume":"14","author":"Lin","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"Suppl 1","key":"10.3233\/JAD-190639_ref18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical dementia rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-190639_ref19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/gerona\/glt155","article-title":"Serum carboxymethyl-lysine, disability, and frailty in older persons: The Cardiovascular Health Study","volume":"69","author":"Whitson","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-190639_ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s11556-016-0163-1","article-title":"The contribution of advanced glycation end product (AGE) accumulation to the decline in motor function","volume":"13","author":"Drenth","year":"2016","journal-title":"Eur Rev Aging Phys Act"},{"key":"10.3233\/JAD-190639_ref21","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","article-title":"Advanced Maillard reaction end products are associated with Alzheimer disease pathology","volume":"91","author":"Smith","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-190639_ref22","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/138161208784139693","article-title":"Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer\u2019s disease","volume":"14","author":"Takeuchi","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-190639_ref23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0925-4439(96)00062-2","article-title":"Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide","volume":"1360","author":"Munch","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-190639_ref24","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","article-title":"Advanced glycation end products contribute to amyloidosis in Alzheimer disease","volume":"91","author":"Vitek","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-190639_ref25","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","article-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation","volume":"33","author":"Li","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-190639_ref26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cercor\/bhh123","article-title":"Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer\u2019s disease brains","volume":"15","author":"Luth","year":"2005","journal-title":"Cereb Cortex"},{"key":"10.3233\/JAD-190639_ref27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nbd.2009.09.008","article-title":"Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer\u2019s disease and diabetes mellitus","volume":"37","author":"Valente","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-190639_ref28","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI118175","article-title":"Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes","volume":"96","author":"Schmidt","year":"1995","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-190639_ref29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2377-7-35","article-title":"Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: Relation to vascular dementia","volume":"7","author":"Southern","year":"2007","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-190639_ref30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(99)02355-7","article-title":"Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer\u2019s disease","volume":"354","author":"Esiri","year":"1999","journal-title":"Lancet"},{"key":"10.3233\/JAD-190639_ref31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.26599\/BSA.2018.9050001","article-title":"Vascular contribution to cognition in stroke and Alzheimer\u2019s disease","volume":"4","author":"Yang","year":"2018","journal-title":"Brain Sci Adv"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:53Z","timestamp":1777370813000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":31,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-190639","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]}}}